We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
-$3.89M
Cap. Flow
+$11.2M
Cap. Flow %
6.35%
Top 10 Hldgs %
22.1%
Holding
256
New
24
Increased
39
Reduced
133
Closed
21

Top Sells

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$3.44M
2
ELAN icon
Elanco Animal Health
ELAN
+$2.97M
3
CNC icon
Centene
CNC
+$2.7M
4
MBB icon
iShares MBS ETF
MBB
+$2.05M
5
LNTH icon
Lantheus
LNTH
+$1.93M

Sector Composition

Rank Sector Weight
1 Healthcare 61.71%
2 Real Estate 10.29%
3 Financials 3.55%
4 Technology 3.29%
5 Energy 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLRN icon
201
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$85K 0.05%
2,768
+27
+1% +$827
EWL icon
202
iShares MSCI Switzerland ETF
EWL
$2.12B
$84.6K 0.05%
1,941
-737
-28% -$33.8K
IGSB icon
203
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$84.2K 0.05%
1,689
+24
+1% +$1.2K
EWG icon
204
iShares MSCI Germany ETF
EWG
$1.5B
$84K 0.05%
3,207
-1,221
-28% -$34K
NCLH icon
205
Norwegian Cruise Line
NCLH
$8.89B
$83.2K 0.05%
5,051
-861
-15% -$15.9K
OVV icon
206
Ovintiv
OVV
$17.5B
$81.3K 0.05%
1,708
-276
-14% -$12.5K
H icon
207
Hyatt Hotels
H
$17.6B
$78.3K 0.04%
738
-125
-14% -$14.2K
WYNN icon
208
Wynn Resorts
WYNN
$10.1B
$77.2K 0.04%
835
-139
-14% -$13.9K
TPR icon
209
Tapestry
TPR
$28.8B
$73K 0.04%
2,538
-253
-9% -$9.26K
AR icon
210
Antero Resources
AR
$10.9B
$69.5K 0.04%
2,737
-466
-15% -$12K
LVS icon
211
Las Vegas Sands
LVS
$30.5B
$67.6K 0.04%
1,475
-245
-14% -$13.2K
ANET icon
212
Arista Networks
ANET
$219B
$50.8K 0.03%
1,104
-188
-15% -$8.38K
DKNG icon
213
DraftKings
DKNG
$11.4B
$50.5K 0.03%
1,715
-293
-15% -$8.66K
HES
214
DELISTED
Hess
HES
$48.2K 0.03%
315
-53
-14% -$7.98K
TTD icon
215
Trade Desk
TTD
$8.13B
$45.6K 0.03%
583
-100
-15% -$8.09K
SRPT icon
216
Sarepta Therapeutics
SRPT
$1.66B
$40.7K 0.02%
336
-57
-15% -$6.44K
MDB icon
217
MongoDB
MDB
$24B
$40.5K 0.02%
117
-20
-15% -$7.59K
DCGO icon
218
DocGo
DCGO
$58.9M
$40K 0.02%
+7,500
New +$60.9K
SNOW icon
219
Snowflake
SNOW
$92.9B
$38.8K 0.02%
254
-44
-15% -$7.16K
FTNT icon
220
Fortinet
FTNT
$112B
$37.6K 0.02%
641
-109
-15% -$7.21K
CFLT
221
DELISTED
Confluent
CFLT
$37K 0.02%
1,249
-212
-15% -$7.1K
MUB icon
222
iShares National Muni Bond ETF
MUB
$45.1B
$35.4K 0.02%
345
-442
-56% -$46.6K
DVN icon
223
Devon Energy
DVN
$51.9B
$33.2K 0.02%
697
-107
-13% -$5.39K
SWAV
224
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$29.7K 0.02%
149
-26
-15% -$6.15K
ALB icon
225
Albemarle
ALB
$13.5B
$28.1K 0.02%
165
-28
-15% -$5.58K

Similar funds

AlphaCentric Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, AlphaCentric Advisors held 256 positions worth $176M, down 2.2% from $180M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors deployed $11.2M of net new capital in Q3 2023, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $1.9M trimmed.

  • AlphaCentric Advisors's largest Q3 2023 buy was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
  • AlphaCentric Advisors added most to Walgreens Boots Alliance in Q3 2023, an estimated $3.86M increase.
  • AlphaCentric Advisors's biggest Q3 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $1.9M.
  • AlphaCentric Advisors fully exited AdaptHealth in Q3 2023, selling an estimated $3.44M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $176M portfolio in Q3 2023.
  • AlphaCentric Advisors opened 24 new positions and closed 21 in Q3 2023.
  • AlphaCentric Advisors's portfolio value fell 2.2% quarter-over-quarter to $176M.

Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.